Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

Established in 1987, Korea United Pharm. Inc. has continued to develop as a pharmaceutical company with its slogan of "Korean owned multinational pharmaceutical company." We have continuously launched new pharmaceutical drugs such as Cilostan CR Tab, Gastiin CR Tab, Clanza CR Tab and etc., through prestigious R&D investment, abundant know-hows and top expert researchers and have been placed as a strong competitor in the pharmaceutical drug development industry. they were named one of Asia's 200 most promising companies by the US economy magazine Forbes.

Pharmacia & Upjohn Co. LLC, a subsidiary of Pfizer Inc., is a company headquartered in Bingham Farms, MI, that manufactures and supplies pharmaceutical goods.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. Its products include health function food, medical equipment, quasi-drugs, over-the-counter drugs, ethical drugs and recommended products such as Binosto effervescent tablet, Tobicom-S soft capsule, Levotension tablet and TobicomKid Q-10 chewable tablets. The company was founded by Noh Jong-Hyeong on September 16, 1955 and is headquartered in Seoul, South Korea.

Nippon Zoki Pharmaceutical Co. Ltd. is a private company headquartered in Chuo-ku, Japan, that manufactures pharmaceutical products.

Shin-Etsu Chemical Co., Ltd. engages in the manufacture and sale of industrial chemicals. Its operations are carried out through the following segments: Polyvinyl Chloride (PVC)/Chlor-Alkali Business, Silicone Business, Specialty Chemicals Business, Semiconductor Silicon Business, Electronics and Functional Materials Business, and Diversified Business. The PVC/Chlor-Alkali Business segment provides PVC, caustic soda, methanol, and chloromethane. The Silicone Business segment provides silicones. The Specialty Chemicals Business segment provides cellulose derivatives, silicon metal, polyvinyl alcohol, and synthetic pheromones. The Semiconductor Silicon Business segment provides silicon wafer products. The Electronics and Functional Materials Business segment provides rare earth magnets, coating materials, photomask blanks, oxide single crystals, and liquid fluoroelastomers. The Diversified Business segment includes processed plastics, international trading, engineering, ad information processing. The company was founded on September 16, 1926 and is headquartered in Tokyo, Japan.

Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others. Its services include custom development and manufacturing services and supply chain management. The company was founded by Il-Han New on June 20, 1926 and is headquartered Seoul, South Korea.

KOS Pharmaceuticals manufactures prescription products for the treatment of chronic cardiovascular diseases. Their products are used treatment of primary hypercholesterolemia and mixed dyslipidemia, mixed lipid disorders, and non dihydropyridine calcium channel blocker, enabling doctors to treat hypertension and chronic stable angina.

Etypharm is a French private company, also operating in FR. The firm provides healthcare services.

Beijing CoSci Med-Tech Co.,Ltd, is a newly developed the research of the pharmaceutical company and an innovative high-tech enterprise subordinated to Beijing Zhongguancun Science and Technology Park.It focuses on preclinical,clinical,early phase drug development and industralizaton research.The company team is made up of veterans from the pharmaceutical industry,prominent scientific experts,and successful business executives.They offer the resoures and the customer-oriented culture for the client from the world to assist to bring the best value for their products. CoSci Med-Tech is at the forefront of the design and the development of sustained-release technique, controlled-release technique and orally disintegrating techniques in China. These technologies are the foundation of their proprietary products.Since CoSci-Med was established,it has provided highly efficient development programs and good market prospects for the drugs and nutritional supplements. By 2009, Cosci Med-Tech co., Ltd has done important work as carrying out theirthe research,development and introduce of new products new technology and establishing strategic partnerships.The company have achieved the registration for the first pharmaceutical prepations from China in EU and developed 80 drug products, applied 107 patents , of which 53 patents have been granted,6 PCTs No matter what type of pharmacologic agent you are working with,CoSci Med-Tech has the capability to support you from development,registration to marketing.We have collaborated with several primary pharmaceutical enterprises at home and abroad. We serve drugs and nutritional supplements client all over the world.We offer programs that are custom designed to meet our clients’ unique situations and needs. CoSci Med-Tech would like to combine its own advantages in helping the foreign businesses to import new products and new technologies ,taking commission processing and open up the big market of China.At the same time,the company can help the China businesses to output new products and new technology into abroad.Abiding the business idea :foundations is in science and technology, honesty is first, cooperation and development,the company would like to carry out active cooperation with the research institutes and universities,pharmaceutical enterprises,medicine distibutors of all countries in the world,and to make contribution to the health of the whole mankind in dedication to their common cause.

Nostrum Pharmaceuticals is engaged in the formulation and commercialization of specialty pharmaceutical products and controlled-release, orally-administered, branded and generic drugs. Nostrum has a rich portfolio of Intellectual Property. Pharmaceutical companies are increasingly utilizing controlled-release drug delivery technologies to improve therapy. These technologies allow for the development of “patient-friendly” dosage forms, which reduce frequency of drug administration, thus improving patient compliance. Controlled-release pharmaceuticals can be especially beneficial for certain patient populations, such as the elderly, who often require several medications with differing dosing regimens.

Engages in priniting activities

Qingdao Haizhiyuan Intelligent Technology Co., Ltd., established on 2015-05-19, Business scope includes technology research and development in the field of mechanical intelligence,technology transfer,High-tech consulting service,Computer software and hardware technology development,technical consulting. (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France.

Acino Pharma AG engages in the development, production, and distribution of chemical and pharmaceutical products. It also acquires, manages, and sells participating interests in firms, real estate, and intellectual property rights. The company was founded in 1961 and is headquartered in Liesberg, Switzerland.